... Bioorganic & Medicinal Chemistry Letters. ... Currently, the approved medical therapies consist of cholinesterase inhibitors and N-methyl d-aspartate (NMDA) antagonists, that reduce the symptomatology of the disease in the initial phase, but do not appear to be capable of ...
